IQVIA
Thousands of organizations around the world trust IQVIA to speed drug development, ensure product quality and safety, improve commercial effectiveness, get the right treatments to patients, improve access to and delivery of healthcare, and ultimately drive better health outcomes. Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster. With a foundation in data, advanced analytics, and expert insight, IQVIA brings specialized capabilities to customers across the healthcare ecosystem. Read and watch the latest from IQVIA data scientists, doctors, researchers, and other subject matter experts on the topics that matter to you. From industry trends to how we are applying our capabilities to help, you can find it here.
Learn more
biologit MLM-AI
Biologit offers a comprehensive suite of software and services designed to enhance safety surveillance across various industries. Their flagship product, biologit MLM-AI, is an all-inclusive global and local medical literature monitoring platform powered by AI. This scientific literature monitoring platform is simple to use, fully web-enabled, and validated for compliance, providing productivity gains for human and veterinary pharmacovigilance. Key features include integrated search and configurable literature screening workflows delivering up to 70% productivity gains powered by AI, a flexible and validated SaaS platform that is GxP-ready and CFR-11 compliant, and a database hosting major global and local literature sources with automatic article de-duplication. In addition to its software solutions, Biologit offers consultancy services covering pharmacovigilance, veterinary pharmacovigilance, and more.
Learn more
Compier Literature Screening
Compier Literature Screening is an AI-driven platform designed to assist pharmacovigilance professionals in efficiently screening abstracts, full texts, and translated articles to identify patients, authors, events, products, and safety-related information. The platform offers built-in integration with online biomedical databases such as Medline and supports bulk uploading of literature records from sources like Embase, conference presentations, and PDF journals. It performs automated duplicate checks for each literature search and utilizes validated AI models for automatic screening and annotation of entities. Users can configure scalable literature screening workflows tailored to specific requirements and global regulations. The system facilitates communication with third-party vendors to obtain full texts and includes built-in translation capabilities. It also integrates with safety systems, such as Oracle Argus Safety, to transmit ICSR-relevant articles.
Learn more
CoVigilAI
CoVigilAI is an AI-enabled medical literature monitoring solution that employs advanced algorithms and data analytics to proactively detect and manage adverse drug events, ensuring patient safety and regulatory compliance in real time. The platform offers streamlined tracking of scientific and medical publications across prominent global literature databases such as PubMed and Embase, with customizable search strings facilitating an effortless pharmacovigilance literature monitoring journey. Periodic surveillance of scientific and medical literature databases and publications from diverse local journals is conducted, encompassing both global literature monitoring and localized literature surveillance. Advanced algorithms categorize Individual Case Safety Reports (ICSRs) into valid, potential, and invalid cases, while automated key entity detection efficiently recognizes crucial entities like patients, medications, adverse events, and designated medical events.
Learn more
